Literature DB >> 23144349

Interventional treatment for acute ischaemic stroke in an 86-year-old.

Amanda Hanora Lavan1, Paul Brennan, Ciaran F Donegan, David J P Williams.   

Abstract

An 86-year-old lady presented to the accident and emergency department with a 90 min history of receptive and expressive dysphasia. There were no motor symptoms or visual symptoms reported. A partial anterior circulation stroke was diagnosed. On examination, she had a National Institutes of Health Stroke Scale of 6. CT angiography showed an occlusive thrombus within the left internal carotid artery extending into the left M1 segment of the middle cerebral artery and the proximal A1 segment of the anterior cerebral artery. Intra-arterial thrombectomy was preformed. Full recovery was achieved.

Entities:  

Mesh:

Year:  2012        PMID: 23144349      PMCID: PMC4543592          DOI: 10.1136/bcr-2012-007200

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  10 in total

1.  Multimodal reperfusion therapy for large hemispheric infarcts in octogenarians: is good outcome a realistic goal?

Authors:  D Arkadir; R Eichel; J M Gomori; T Ben Hur; J E Cohen; R R Leker
Journal:  AJNR Am J Neuroradiol       Date:  2012-02-02       Impact factor: 3.825

2.  Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism.

Authors:  A Furlan; R Higashida; L Wechsler; M Gent; H Rowley; C Kase; M Pessin; A Ahuja; F Callahan; W M Clark; F Silver; F Rivera
Journal:  JAMA       Date:  1999-12-01       Impact factor: 56.272

3.  Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials.

Authors:  Kennedy R Lees; Erich Bluhmki; Rüdiger von Kummer; Thomas G Brott; Danilo Toni; James C Grotta; Gregory W Albers; Markku Kaste; John R Marler; Scott A Hamilton; Barbara C Tilley; Stephen M Davis; Geoffrey A Donnan; Werner Hacke; Kathryn Allen; Jochen Mau; Dieter Meier; Gregory del Zoppo; D A De Silva; K S Butcher; M W Parsons; P A Barber; C Levi; C Bladin; G Byrnes
Journal:  Lancet       Date:  2010-05-15       Impact factor: 79.321

4.  The impact of recanalization on ischemic stroke outcome: a meta-analysis.

Authors:  Joung-Ho Rha; Jeffrey L Saver
Journal:  Stroke       Date:  2007-02-01       Impact factor: 7.914

5.  A randomized trial of tenecteplase versus alteplase for acute ischemic stroke.

Authors:  Mark Parsons; Neil Spratt; Andrew Bivard; Bruce Campbell; Kong Chung; Ferdinand Miteff; Bill O'Brien; Christopher Bladin; Patrick McElduff; Chris Allen; Grant Bateman; Geoffrey Donnan; Stephen Davis; Christopher Levi
Journal:  N Engl J Med       Date:  2012-03-22       Impact factor: 91.245

6.  Good clinical outcome after ischemic stroke with successful revascularization is time-dependent.

Authors:  P Khatri; T Abruzzo; S D Yeatts; C Nichols; J P Broderick; T A Tomsick
Journal:  Neurology       Date:  2009-09-29       Impact factor: 9.910

7.  Elderly patients are at higher risk for poor outcomes after intra-arterial therapy.

Authors:  Ronil V Chandra; Thabele M Leslie-Mazwi; Daniel C Oh; Zeshan A Chaudhry; Brijesh P Mehta; Natalia S Rost; James D Rabinov; Joshua A Hirsch; R Gilberto González; Lee H Schwamm; Albert J Yoo
Journal:  Stroke       Date:  2012-06-28       Impact factor: 7.914

8.  Predictors of good clinical outcomes, mortality, and successful revascularization in patients with acute ischemic stroke undergoing thrombectomy: pooled analysis of the Mechanical Embolus Removal in Cerebral Ischemia (MERCI) and Multi MERCI Trials.

Authors:  Raul G Nogueira; David S Liebeskind; Gene Sung; Gary Duckwiler; Wade S Smith
Journal:  Stroke       Date:  2009-10-29       Impact factor: 7.914

Review 9.  Treatment time-specific number needed to treat estimates for tissue plasminogen activator therapy in acute stroke based on shifts over the entire range of the modified Rankin Scale.

Authors:  Maarten G Lansberg; Maarten Schrooten; Erich Bluhmki; Vincent N Thijs; Jeffrey L Saver
Journal:  Stroke       Date:  2009-04-16       Impact factor: 7.914

10.  The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial.

Authors:  Peter Sandercock; Joanna M Wardlaw; Richard I Lindley; Martin Dennis; Geoff Cohen; Gordon Murray; Karen Innes; Graham Venables; Anna Czlonkowska; Adam Kobayashi; Stefano Ricci; Veronica Murray; Eivind Berge; Karsten Bruins Slot; Graeme J Hankey; Manuel Correia; Andre Peeters; Karl Matz; Phillippe Lyrer; Gord Gubitz; Stephen J Phillips; Antonio Arauz
Journal:  Lancet       Date:  2012-05-23       Impact factor: 79.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.